AGM
ACHV icon

Alpine Global Management’s Achieve Life Sciences ACHV Stock Holding History

Alpine Global Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.6K Sell
12,500
-37,500
-75% -$179K 0.01% 219
2026
Q1 		$147K Sell
50,000
-33,481
-40% -$149K 0.02% 174
2025
Q4 		$415K Buy
+83,481
New +$364K 0.09% 111
2025
Q3 		– Sell
-100,000
Closed -$226K – 240
2025
Q2 		$226K Buy
+100,000
New +$285K 0.05% 115

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Alpine Global Management's ACHV Position: Q2 2026 in Review

Alpine Global Management reduced its Achieve Life Sciences (ACHV) stake by 75% in Q2 2026, selling an estimated $179K and leaving 12,500 shares worth $81.6K. The position accounts for 0.01% of the portfolio, ranked #219.

Alpine Global Management first reported a position in ACHV in Q2 2025 and has held it in 4 quarters since. The position peaked at $415K in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Alpine Global Management held 12,500 shares of Achieve Life Sciences worth $81.6K as of Q2 2026.
  • Alpine Global Management sold 37,500 Achieve Life Sciences shares in Q2 2026, an estimated $179K.
  • Achieve Life Sciences made up 0.01% of Alpine Global Management's portfolio in Q2 2026, its #219 holding.
  • Alpine Global Management first reported a position in Achieve Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Alpine Global Management's Achieve Life Sciences position peaked at $415K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.